It has been already well described that mutant p53 associates with SREBP2 and upregulates HMGCR and other MVA genes in BC cells, making the cells highly responsive on the flux through the MVA pathway and sensitive to its inhibition [78]. This evidence concerns the gene SREBF2 and breast cancer.